INmune Bio Inc.
INmune Bio is focused on modulating components of the innate immune system to activate an immune response to diseases.
23 employees · est. 2015 · Boca Raton, United States
Janux Therapeutics
Developing unique immunotherapies that generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue
120 employees · est. 2017 · San Diego, United States
INmune Bio Inc. is the older company (2015 vs 2017); Janux Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | INmune Bio Inc. | Janux Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2017 |
| Headquarters | ||
| Headquarters | Boca Raton, United States | San Diego, United States |
| Employees | ||
| Employees | 23 | 120 larger |
| Industry | ||
| Industry | Biotechnology, Industrial | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $112.91M | $825.30M |
| Funding Rounds | ||
| Funding Rounds | 8 | 6 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Oncology, Clinical Stage, Cancer Treatment, Immune System Modulation, Precision Medicine, Residual Disease, NK Cells, Cancer Relapse, Drug Candidates, Immune Response, Immune System Activation, Immuno-oncology, Precision Medicine Approach | Biopharmaceutical, Cancer Therapy, T Cell Engagers, Oncology, Immune System Modulation, Solid Tumors, Drug Development, Oncology Research, Immune-mediated Therapies |
| Website | ||
| Website | inmunebio.com | januxrx.com |
About INmune Bio Inc.
INmune Bio Inc. is a biotechnology startup founded in 2015, headquartered in the United States. The company's focus is on modulating components of the innate immune system to activate an immune response to diseases. Their lead product, INKmune, primes patient’s NK cells (natural killer cells) to kil...
About Janux Therapeutics
Janux Therapeutics is an innovative biopharmaceutical company founded in 2017 and based in the United States. The company is focused on developing next-generation therapeutics through its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology with the aim of providing more effective...
We will tell you when either one moves
BounceWatch watches INmune Bio Inc. and Janux Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at INmune Bio Inc. and Janux Therapeutics — by email.
Frequently Asked Questions
Compare INmune Bio Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at INmune Bio Inc. on 11 Sep 2024, and Janux Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
